idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Knock-on funding to establish a junior research group at the University Medical Center in Göttingen, Germany, to study acute pulmonary failure.
Crucial research needed to address the shortcomings of current concepts and therapy recommendations not directly applicable to treating severe lung failure caused by COVID-19 disease
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is supporting the University Medical Center in Göttingen, Germany (UMG), with 500,000 euros for conducting research on COVID-19 associated disease. Over the next three years, the Department of Anesthesiology at UMG will use this funding to investigate the development and progression of SARS-CoV2-mediated lung disease and the effect of specific ventilation therapies on COVID-19 patients, among other studies. The University Medical Center Göttingen is considered a leading international medical center for translational research and further clinical development in the prevention, diagnosis, therapy and follow-up care of acute pulmonary failure. It aims to set up a junior research group called “Akutes Lungenversagen” to study SARS-CoV2-mediated acute pulmonary failure, in relation to acute respiratory distress syndrome (ARDS).
“The current coronavirus pandemic and comparable epidemics highlight the importance of treating severe lung disease correctly. Practical clinical research, conducted by a high-caliber junior research group, will make significant contributions to this field, further strengthening one of UMG’s clinical and research areas of excellence,” commented Sartorius Executive Board Chairman and CEO Dr. Joachim Kreuzburg. Against the backdrop of the COVID-19 pandemic, the Supervisory Board and the Executive Board of Sartorius AG announced that the company would support people and institutions hit particularly hard by this crisis, or that that play a key role in coping with it.
For more than 20 years, acute pulmonary failure and ventilation medicine have been a major focus of research at the Department of Anesthesiology of the UMG. This is why the expertise available at this clinic is in high demand worldwide in light of the current pandemic. Since there is little systematic data on SARS-CoV2-mediated disease, scientists and clinicians are working intensively on studies to discover the appropriate diagnostics and therapy for acute pulmonary failure caused by COVID-19. This is where the UMG junior research group will come in, which can rely on established structures and experienced mentors to facilitate its investigations.
“So far, available concepts and therapy recommendations for acute pulmonary failure could not be adopted seamlessly to treat COVID-19 pulmonary disease. Therefore, this research is essential to facilitate appropriate diagnostic and therapeutic recommendations for seriously ill COVID-19 patients. With this donation, Sartorius is providing us with crucial funding to explore additional research opportunities," emphasized Professor Dr. Wolfgang Brück, Chair of the Executive Board of the University Medical Center in Göttingen.
“Over the next three years, we aim to set up the required foundation for a junior research group [at the UMG]. The research project at the Department of Anesthesiology pursues the objective of establishing a leading role in conducting multicentric clinical studies through internationally networked basic and translational research. Sartorius' donation not only enables us to further develop excellent young scientists, who may thereby eventually qualify to join programs such as the Heisenberg Program of the German Research Foundation (DFG), thus creating long-term research prospects at the University Medical Center in Göttingen," said Dr. Konrad Meissner, Professor and Director of the Department of Anesthesiology at the UMG.
A profile of Sartorius
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2019, the company earned sales revenue of some 1.83 billion euros. At the end of 2019, more than 9,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
Contact
Andre Hofmann
Head of Public Relations
+49 (0)551.308.5096
andre.hofmann@sartorius.com
sartorius.com
Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.
University Medical Center Göttingen, Georg-August-Universität
Department of Anesthesiology
Director: Prof. Dr. Konrad Meissner
+49 (0) 551. 39-67701
konrad.meissner@med.uni-goettingen.de
ains.umg.eu
Merkmale dieser Pressemitteilung:
Journalisten
Medizin
überregional
Forschungsprojekte, Wissenschaftspolitik
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
